Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

Risks of congenital malformations and perinatal events among infants exposed to calcium channel and beta-blockers during pregnancy.

Davis RL, Eastman D, McPhillips H, Raebel MA, Andrade SE, Smith D, Yood MU, Dublin S, Platt R.

Pharmacoepidemiol Drug Saf. 2011 Feb;20(2):138-45. doi: 10.1002/pds.2068. Epub 2010 Nov 15.

2.

Risks of congenital malformations and perinatal events among infants exposed to antidepressant medications during pregnancy.

Davis RL, Rubanowice D, McPhillips H, Raebel MA, Andrade SE, Smith D, Yood MU, Platt R; HMO Research Network Center for Education, Research in Therapeutics.

Pharmacoepidemiol Drug Saf. 2007 Oct;16(10):1086-94. Review.

PMID:
17729378
3.

The risk of limb deficiencies and other congenital abnormalities in children exposed in utero to calcium channel blockers.

Sørensen HT, Czeizel AE, Rockenbauer M, Steffensen FH, Olsen J.

Acta Obstet Gynecol Scand. 2001 May;80(5):397-401.

PMID:
11328214
4.

Antidepressant medication use and risk of persistent pulmonary hypertension of the newborn.

Andrade SE, McPhillips H, Loren D, Raebel MA, Lane K, Livingston J, Boudreau DM, Smith DH, Davis RL, Willy ME, Platt R.

Pharmacoepidemiol Drug Saf. 2009 Mar;18(3):246-52. doi: 10.1002/pds.1710.

PMID:
19148882
5.

Calcium Channel Blocker Exposure in Late Pregnancy and the Risk of Neonatal Seizures.

Bateman BT, Huybrechts KF, Maeda A, Desai R, Patorno E, Seely EW, Ecker JL, Allen-Coleman C, Mogun H, Hernandez-Diaz S, Fischer MA.

Obstet Gynecol. 2015 Aug;126(2):271-8. doi: 10.1097/AOG.0000000000000908.

6.

Antihypertensive drugs and the risk of congenital anomalies.

Vasilakis-Scaramozza C, Aschengrau A, Cabral HJ, Jick SS.

Pharmacotherapy. 2013 May;33(5):476-82. doi: 10.1002/phar.1212. Epub 2013 Apr 1.

PMID:
23553869
7.

The safety of calcium channel blockers during pregnancy: a prospective, multicenter, observational study.

Weber-Schoendorfer C, Hannemann D, Meister R, Eléfant E, Cuppers-Maarschalkerweerd B, Arnon J, Vial T, Rodriguez-Pinilla E, Clementi M, Robert-Gnansia E, De Santis M, Malm H, Dolivo A, Schaefer C.

Reprod Toxicol. 2008 Sep;26(1):24-30. doi: 10.1016/j.reprotox.2008.05.065. Epub 2008 Jun 7.

PMID:
18585452
8.

Fetal effects of anticonvulsant polytherapies: different risks from different drug combinations.

Holmes LB, Mittendorf R, Shen A, Smith CR, Hernandez-Diaz S.

Arch Neurol. 2011 Oct;68(10):1275-81. doi: 10.1001/archneurol.2011.133. Epub 2011 Jun 13.

PMID:
21670385
9.

Birth outcome and risk of neonatal hypoglycaemia following in utero exposure to pivmecillinam: a population-based cohort study with 414 exposed pregnancies.

Larsen H, Nielsen GL, Møller M, Ebbesen F, Schønheyder HC, Sørensen HT.

Scand J Infect Dis. 2001;33(6):439-44.

PMID:
11450863
10.

[In utero exposure to benzodiazepine. Is there a risk for anal atresia with lorazepam?].

Bonnot O, Vollset SE, Godet PF, d'Amato T, Dalery J, Robert E.

Encephale. 2003 Nov-Dec;29(6):553-9. Review. French.

PMID:
15029090
12.

Valproic acid monotherapy in pregnancy and major congenital malformations.

Jentink J, Loane MA, Dolk H, Barisic I, Garne E, Morris JK, de Jong-van den Berg LT; EUROCAT Antiepileptic Study Working Group.

N Engl J Med. 2010 Jun 10;362(23):2185-93. doi: 10.1056/NEJMoa0907328. Review.

14.

[Neonatal outcome after exposure to beta adrenergic blockers late in pregnancy].

Cissoko H, Jonville-Béra AP, Swortfiguer D, Giraudeau B, Autret-Leca E.

Arch Pediatr. 2005 May;12(5):543-7. French.

PMID:
15885543
15.

Contraception, pregnancy and lactation in women with epilepsy.

Yerby MS.

Baillieres Clin Neurol. 1996 Dec;5(4):887-908. Review.

PMID:
9068887
16.

The effects of benzodiazepine use during pregnancy and lactation.

McElhatton PR.

Reprod Toxicol. 1994 Nov-Dec;8(6):461-75. Review.

PMID:
7881198
17.

First trimester exposure to paroxetine and risk of cardiac malformations in infants: the importance of dosage.

Bérard A, Ramos E, Rey E, Blais L, St-André M, Oraichi D.

Birth Defects Res B Dev Reprod Toxicol. 2007 Feb;80(1):18-27.

PMID:
17187388
18.

Exposure to folic acid antagonists during the first trimester of pregnancy and the risk of major malformations.

Matok I, Gorodischer R, Koren G, Landau D, Wiznitzer A, Levy A.

Br J Clin Pharmacol. 2009 Dec;68(6):956-62. doi: 10.1111/j.1365-2125.2009.03544.x.

19.

The frequency of neonatal morbidity after exposure to antiepileptic drugs in utero: a retrospective population-based study.

Burja S, Rakovec-Felser Z, Treiber M, Hajdinjak D, Gajsek-Marchetti M.

Wien Klin Wochenschr. 2006;118 Suppl 2:12-6.

PMID:
16817037
20.

The safety of calcium channel blockers in human pregnancy: a prospective, multicenter cohort study.

Magee LA, Schick B, Donnenfeld AE, Sage SR, Conover B, Cook L, McElhatton PR, Schmidt MA, Koren G.

Am J Obstet Gynecol. 1996 Mar;174(3):823-8.

PMID:
8633650
Items per page

Supplemental Content

Write to the Help Desk